v3.26.3
Equity Method Investment - Schedule of Condensed Statement of Operations (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2026
Jun. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2026
Sep. 30, 2025
Schedule of Condensed Income Statement [Line Items]                
Goodwill Impairment $ 0           $ 0  
Net income (loss) (19,811,226) $ (8,533,565) $ (49,825,541) $ (4,012,159) $ 2,513,213 $ 14,878,658 (78,170,332) $ 13,379,712
VIE [Member]                
Schedule of Condensed Income Statement [Line Items]                
Revenue 23,993     0     23,993 0
Cost of sales 24,973     0     24,973 0
Gross loss (980)     0     (980) 0
Operating expenses (4,735,466)     (4,045,745)     (15,293,942) (12,995,206)
In-process research and development impairment (46,900,000)     0     (157,200,000) 0
Goodwill Impairment 0     (154,793,000)     (76,096,000) (154,793,000)
Other income 12,192     28,107     48,034 337,678
Net income (loss) $ (51,624,254)     $ (158,810,638)     $ (248,542,888) $ (167,450,528)